Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| 2017/0128479 |
TREATMENT OF PEROXISOME BIOGENESIS DISORDER A method is described for treating a peroxisome biogenesis disorder by administering to an individual in need thereof an effective amount of an autophagy... |
| 2017/0128478 |
Skin Treatment Lotion A system and method for a skin treatment lotion. The lotion has a protecting agent, a moisture absorber, a binding agent, water, and an antibiotic agent or... |
| 2017/0128477 |
COMPOSITION FOR INHIBITING MYELOID-DERIVED SUPPRESSOR CELLS COMPRISING
DECITABINE OR ITS PHARMACEUTICALLY... The present invention relates to a method for inhibiting myeloid-derived suppressor cells or treating cancer comprising administering a pharmaceutical... |
| 2017/0128476 |
FAP-Activated Therapeutic Agents, and Uses Related Thereto Disclosed are prodrugs of anthracyclines (such as doxorubicin) and derivatives thereof that are selectively cleaved and activated by fibroblast activating... |
| 2017/0128475 |
COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING ORGAN INJURY AND/OR
DYSFUNCTION The present embodiments relate to compositions and methods for treating the inflammatory response in a tissue or organ, such as the liver, by contacting the... |
| 2017/0128474 |
METHOD FOR TREATING CANCER USING CHEMOKINE ANTAGONISTS What is described is a method for treating cancer in a patient in need of such treatment through the use of an antagonist to CXCR1 and/or CXCR2 receptors by... |
| 2017/0128473 |
Vesicular Formulations for Use in the Treatment of Pain or Reduced
Mobility of a Joint The present invention relates to vesicular formulations for use in the treatment of pain and/or reduced mobility associated with a loss of lubrication and/or... |
| 2017/0128472 |
Administration of Zoledronic Acid to Treat Pain Associated with Ankylosing
Spondylitis Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid in an acid or a salt form, can be used to... |
| 2017/0128471 |
COMBINATION THERAPY TO TREAT MYCOBACTERIUM DISEASES The present invention relates to a compound of formula (I) ##STR00001## or a pharmaceutically acceptable salt thereof wherein X and R are as defined herein. The... |
| 2017/0128470 |
COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED
COMPOUNDS FOR TREATING PAGET'S DISEASE OF BONE Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid in an acid or a salt form, or in a molecular... |
| 2017/0128469 |
COMPOSITION CONTAINING PHYTIC ACID, MAGNESIUM AND POLYPHENOLS FOR THE
TREATMENT OR PREVENTION OF RENAL LITHIASIS The present invention is related to a composition comprising phytic acid or a phytate salt, magnesium in the form of salt, hydroxide or oxide and optionally at... |
| 2017/0128468 |
PHOSPHATIDYLGLYCEROL AS AN ANTI-INFLAMMATORY Compositions and methods for reducing, or inhibiting inflammation in a subject in need thereof have been developed. Pharmaceutical compositions including one... |
| 2017/0128467 |
ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS WITH MULTIPLE DRUG RESISTANCE
INHIBITING PROPERTIES The invention provides a method for treating a microbial infection in an infected subject comprising administering to the subject an antimicrobial composition... |
| 2017/0128466 |
USE OF CANTHAXANTHIN AND/OR 25-OH D3 FOR IMPROVED HATCHABILITY IN POULTRY The present invention relates to the use canthaxanthin and/or 25-hydroxy vitamin D3 (25-OH D3) for improving breeder hatchability and fertility and for... |
| 2017/0128465 |
Pharmaceutical Compositions and Methods This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating... |
| 2017/0128464 |
Porous silicon drug-eluting particles The invention provides a biodegradable drug-eluting particle useful for the delivery of diagnostic or therapeutic agents. In certain embodiments, the... |
| 2017/0128463 |
ROCURONIUM PREPARATION WITH IMPROVED STABILITY The present invention provides a rocuronium preparation with an excellent stability. The rocuronium preparation contains rocuronium and a buffer solution and... |
| 2017/0128462 |
METHODS FOR TREATING FEMALE SEXUAL DYSFUNCTION WHILE DECREASING
CARDIOVASCULAR RISK Methods for treating female sexual dysfunction are provided. In particular, methods for treating a woman having HSDD by administering to the woman a... |
| 2017/0128461 |
SHIP INHIBITION TO INDUCE EXPRESSION OF GRANULOCYTE COLONY STIMULATING
FACTOR IN A SUBJECT The present invention relates to the use SHIP inhibitors to induce expression of granulocyte colony stimulating factor (G-CSF) in a subject, thereby promoting... |
| 2017/0128460 |
Cyclic Amines The present invention is directed to novel cyclic amines which inhibit the P2X7 receptor. |
| 2017/0128459 |
PHARMACEUTICAL COMPOSITION CONTAINING SIRT2 INHIBITOR The present invention relates to a pharmaceutical composition containing a SIRT2 inhibitor and, more specifically, to: a pharmaceutical composition for... |
| 2017/0128458 |
COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed. ... |
| 2017/0128457 |
Treatment of Conditions Through Pharmacological Modulation of the
Autonomic Nervous System Methods are provided for treating a subject for a condition caused by an abnormality in the subject's autonomic nervous system. In accordance with the subject... |
| 2017/0128456 |
CARBON MONOXIDE-RELEASING MOLECULES FOR THERAPEUTIC APPLICATIONS AND
METHODS OF MAKING AND USING THEREOF Carbon monoxide-releasing organic molecules are described herein. The molecules can be synthesized prior to administration (e.g., ex vivo) or formed in vivo.... |
| 2017/0128455 |
COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES A pharmaceutical composition comprising: (a) a compound of formula 1 ##STR00001## wherein: n is 1 or 2; R.sup.1 is hydrogen, halogen, C.sub.1-4-alkyl, or ... |
| 2017/0128454 |
COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE Provided are compounds of Formula I: ##STR00001## as described herein. Compounds of Formula I are useful in methods of inhibiting viral RNA polymerase activity... |
| 2017/0128453 |
NOVEL USES The subject matter generally relates to methods of treatment and/or prophylaxis of CNS diseases, disorders, and/or injuries. In one aspect, the subject matter... |
| 2017/0128452 |
Aminopterin Dosage Forms Embodiments of the present invention provide dosage forms and methods for treating a patient with an inflammatory disorder with a therapeutically effective... |
| 2017/0128451 |
DOSING REGIMEN ASSOCIATED WITH LONG ACTING INJECTABLE PALIPERIDONE ESTERS The present invention provides a method of treating patients in need of treatment with long acting injectable paliperidone palmitate formulations. |
| 2017/0128450 |
SMALL MOLECULE INHIBITORS OF INFLUENZA A RNA-DEPENDENT RNA POLYMERASE Antiviral compositions and methods are contemplated that are especially effective in the treatment and prevention of influenza A viruses. Also presented are... |
| 2017/0128449 |
MEDICINAL COMPOSITION INHIBITING NEOVASCULARIZATION PROLIFERATION FACTOR A pharmaceutical composition for neovascular diseases, a pharmaceutical composition for inhibiting an angiogenic growth factor, and use of these pharmaceutical... |
| 2017/0128447 |
Inhibitors of Multidrug Resistance Transporter P-Glycoprotein The present disclosure provides a method of treating a subject that is resistant to one or more drugs by identifying a subject having one or more drug... |
| 2017/0128446 |
USE OF BUSPIRONE METABOLITES The present invention is directed to a composition comprising a buspirone metabolite, alone or in combination with a second active ingredient, for use in the... |
| 2017/0128445 |
Fused Imidazole and Pyrazole Derivatives as Modulators of TNF Activity A series of substituted benzimidazole, imidazo[1,2-.alpha.]pyridine and pyrazolo[1,5-.alpha.]pyridine derivatives, and analogues thereof, being potent... |
| 2017/0128444 |
POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): ##STR00001## ... |
| 2017/0128443 |
POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): ##STR00001## ... |
| 2017/0128442 |
TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM A process of production of trazodone or trazodone hydrochloride that comprises: (a) preparing an organic phase comprising trazodone in at least one organic... |
| 2017/0128441 |
PHARMACEUTICAL FOR TREATING DIZZINESS HAVING DIFFERENT CAUSES The invention relates to a dosage form that is suitable for releasing an active ingredient over a long period of time. For this purpose, the active ingredient... |
| 2017/0128440 |
TAMPER RESISTANT DOSAGE FORMS The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of... |
| 2017/0128439 |
NEW BRUTON'S TYROSINE KINASE INHIBITOR The present invention provides a Bruton's tyrosine kinase inhibitor, which is a compound represented by formula (I) or a pharmaceutically acceptable salt,... |
| 2017/0128438 |
Nano- And Micro-Sized Particles of 20-Camptothecin Or Derivative Thereof
And Pharmaceutical Compositions... A pharmaceutical composition is provided having particles of a physical mixture that contain at least one 20-camptothecin or a derivative thereof, at least one... |
| 2017/0128437 |
AMINO-QUINOLINES AS KINASE INHIBITORS Disclosed are compounds having the formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3 and Z are as defined herein, and methods of making and using the same. |
| 2017/0128436 |
Treatment of Glaucoma Using Laquinimod The subject invention provides a method of treating a subject afflicted with glaucoma, suffering from retinal ganglion cell (RGC) loss or damage, or elevated... |
| 2017/0128435 |
TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting... |
| 2017/0128434 |
NOVEL ESTROGEN RECEPTOR LIGANDS Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in... |
| 2017/0128433 |
Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition
Requiring an Immunosuppressive Activity The present invention relates to the general field of treatment and prevention of diseases involving an inflammatory condition, namely sepsis or infectious or... |
| 2017/0128432 |
COMPOSITIONS COMPRISING NICOTINIC AGONISTS AND METHODS OF USING SAME The disclosure is directed at least in part to compositions and methods comprising nicotinic agonists for treating e.g., nervous system disorders, in... |
| 2017/0128431 |
4-ALKYNYL IMIDAZOLE DERIVATIVE AND MEDICINE COMPRISING SAME AS ACTIVE
INGREDIENT There are provided 4-alkynylimidazole derivatives represented by the following general formula (I) or pharmaceutically acceptable salts thereof; the... |
| 2017/0128430 |
UCP-1 Expression Promoter It is intended to provide a drug, a quasi-drug, a dermatological preparation for external use, or a material to be contained to drugs, quasi-drugs,... |
| 2017/0128429 |
Methods of Administering Pirfenidone Therapy The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.